1. Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
   Hanna Ronkainen et al, 2011, Journal of Experimental & Clinical Cancer Research CrossRef
2. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells
   TETSUJI TANAKA et al, 2012, Oncology Reports CrossRef
3. Immunobiology of hepatocellular carcinoma
   Tobias Flecken et al, 2012, Langenbeck's Archives of Surgery CrossRef
4. CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin
   Sheng-ran Liang et al, 2013, Cancer Cell International CrossRef
5. In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer
   Ayele H. Negussie et al, 2022, Scientific Reports CrossRef
6. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention
   Hai Zou et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
7. Targeting Toll-Like Receptors for Cancer Therapy
   Marc J. Braunstein et al, 2018, Targeted Oncology CrossRef
8. Estrogen-related genome-based expression profiling study of uterosacral ligaments in women with pelvic organ prolapse
   Yeo Jung Moon et al, 2013, International Urogynecology Journal CrossRef
9. Pattern Recognition Receptors and Aging
   Karim H. Shalaby, 2014, Immunology of Aging CrossRef
10. Immunopathology of Hepatobiliary Tumors and Immunotherapy of Liver Cancers
    Zhen-Yu Ding et al, 2015, Cancer Immunology CrossRef
11. Evaluating DAPK as a therapeutic target
    Yide Huang et al, 2014, Apoptosis CrossRef
12. Surface toll-like receptor 9 on immune cells and its immunomodulatory effect
    Mengyuan Kou et al, 2023, Frontiers in Immunology CrossRef
13. The role of death-associated protein kinase (DAPK) in endothelial apoptosis under fluid shear stress
    Keith Rennier et al, 2013, Life Sciences CrossRef
14. Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds
    Ahmed K. Farag et al, 2020, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
15. TLR9 -1486C/T Polymorphism Is Associated with Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Sara de la Fuente et al, 2019, Biomarkers in Medicine CrossRef